Showing results (1-10 of 159) with videos related to
Sort By:
Pageof 16
Zeitschrift Fur Gastroenterologie|November 21, 2007
[Medication therapeutic strategies for gastro-esophageal reflux disease]J Labenz, A LeodolterInternational Journal of Clinical Practice|February 28, 2015
Management of reflux esophagitis: does the choice of proton pump inhibitor matter?J Labenz, D Armstrong, A Leodolter, et al.Alimentary Pharmacology & Therapeutics|February 19, 2009
Clinical trial: factors associated with resolution of heartburn in patients with reflux oesophagitis--results from the EXPO studyJ Labenz, D Armstrong, S Zetterstrand, et al.Alimentary Pharmacology & Therapeutics|March 21, 2009
Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis--results from the maintenance phase of the EXPO studyJ Labenz, D Armstrong, S Zetterstrand, et al.Alimentary Pharmacology & Therapeutics|February 3, 2009
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD studyM Nocon, J Labenz, D Jaspersen, et al.Zeitschrift Fur Gerontologie|July 1, 1993
[Biliary diseases in the elderly: diagnosis and therapy]J LabenzAlimentary Pharmacology & Therapeutics|February 28, 2002
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized studyUlrich Peitz, M Sulliga, K Wolle, et al.Alimentary Pharmacology & Therapeutics|February 27, 2009
Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-upD Jaspersen, M Nocon, J Labenz, et al.Bailliere'S Best Practice & Research. Clinical Gastroenterology|April 5, 2000
Consequences of Helicobacter pylori cure in ulcer patientsJ LabenzPageof 16